Sökning: "Thrombin activatable fibrinolysis inhibitor TAFI"

Hittade 3 avhandlingar innehållade orden Thrombin activatable fibrinolysis inhibitor TAFI.

  1. 1. Thrombin activatable fibrinolysis inhibitor (TAFI) in different hemorrhagic and thrombotic conditions

    Författare :Jovan P Antovic; Karolinska Institutet; Karolinska Institutet; []
    Nyckelord :Thrombin activatable fibrinolysis inhibitor TAFI ; coagulation; fibrinolysis; thrombin; plasmin; factor V Leiden; hemophilia; von Willebrand disease; diabetes mellitus; preeclampsia;

    Sammanfattning : Until recently the coagulation and fibrinolytic systems were usually considered as separate entities. Accounts of a fibrinolysis inhibitor that is generated by thrombin shed more light on this field and changed the concept by giving thrombin, the pivotal enzyme in hemostasis, another important role in the down-regulation of fibrinolysis. LÄS MER

  3. 2. On the induction of inflammatory reactions by Streptococcus pyogenes

    Författare :Lisa Påhlman; Infektionsmedicin; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; mycology; Mikrobiologi; bakteriologi; virologi; mykologi; virology; bacteriology; Microbiology; Streptococcal collagen-like surface protein; M protein; Inflammation; Streptococcus pyogenes;

    Sammanfattning : Streptococcus pyogenes is an important human pathogen that causes significant morbidity and mortality worldwide. In order to successfully infect the human host, S. pyogenes is equipped with tools that modulate the human immune defence. LÄS MER

  4. 3. Thrombotic and cardiac disease in the antiphospholipid syndrome

    Författare :Giorgia Grosso; Karolinska Institutet; Karolinska Institutet; []
    Nyckelord :;

    Sammanfattning : The antiphospholipid syndrome (APS) is a highly heterogeneous disease that presents with obstetric complications and/or thromboembolic events that can hit any side of the vascular tree in an unpredictable way. The common trait among all patients affected by the syndrome is the persistent presence of the antiphospholipid antibodies (aPL) and/or a prolonged coagulation time in vitro, the lupus anticoagulant (LA) test. LÄS MER